<p>Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Daniel Grant, MD, vice president and global program head of neuroscience and gene therapy at Swiss pharma giant Novartis, on emerging therapies for SMA.</p>

Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Daniel Grant, MD, vice president and global program head of neuroscience and gene therapy at Swiss pharma giant Novartis, on emerging therapies for SMA.

An Interview With Dr. Daniel Grant, VP and Global Program Head at Novartis

Rare Disease Advisor's Rare Care Podcast features exclusive interviews with experts and stakeholders from the rare disease community.

Share An Interview With Dr. Daniel Grant, VP and Global Program Head at Novartis

Sign up to save your podcasts

An Interview With Dr. Daniel Grant, VP and Global Program Head at Novartis

An Interview With Dr. Daniel Grant, VP and Global Program Head at Novartis